Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CryoStor CS10 + ringer's lactate is a specialized formulation used as a cryopreservation and delivery vehicle for cell-based therapies. CryoStor CS10 is a commercially available, protein-free, and serum-free medium containing 10% dimethyl sulfoxide (DMSO), designed to mitigate cold-induced molecular stress and maintain cell viability during freezing and thawing. Ringer's lactate is an isotonic crystalloid solution containing sodium chloride, sodium lactate, potassium chloride, and calcium chloride. In clinical trials such as the ScarASC study for hypertrophic scars, this combination is used to suspend adipose-derived regenerative cells (ADRCs) for intralesional injection, providing a stable environment that balances cryoprotection with physiological compatibility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CryoStor CS10 + ringer's lactate.